Non-recommended DOAC Dosing Associated with Higher Mortality Risk, Study Shows
A new study from the GARFIELD-AF registry shows that patients who received non-recommended dosing of direct oral anticoagulants (underdosage and overdosage combined) were noted to have higher mortality than patients who received standard dosing.